Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel
OTCMKTS:DGNOF

DIAGNOS Q2 2026 Earnings Report

DIAGNOS logo
$0.34 -0.01 (-1.97%)
As of 10:08 AM Eastern
ProfileEarnings History

DIAGNOS EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

DIAGNOS Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

DIAGNOS Announcement Details

Quarter
Q2 2026
Date
11/20/2025
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

DIAGNOS Earnings Headlines

DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344835/0/en/diagnos-receives-saudi-fda-medical-device-license-for-cara-system-bringing-ai-assisted-retinal-image-analysis-to-saudi-arabia.html
DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333833/0/en/diagnos-receives-health-canada-medical-device-licence-for-cara-system-bringing-ai-assisted-retinal-image-analysis-to-canadian-optometrists.html
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel
September 4 at 1:00 AM  |  Paradigm Press (Ad)
Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
June 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/05/3307455/0/en/emerging-growth-research-releases-flash-report-on-diagnos-highlighting-regulatory-catalysts-and-commercialization-potential-for-cara-ai-platform.html
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
June 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/03/3306199/0/en/diagnos-to-present-at-the-emerging-growth-conference-on-june-10-2026.html
DIAGNOS Announces Amendment to Convertible Debentures
May 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3294556/0/en/diagnos-announces-amendment-to-convertible-debentures.html
See More DIAGNOS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DIAGNOS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your email.

About DIAGNOS

DIAGNOS (OTCMKTS:DGNOF) provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

View DIAGNOS Profile
Earnings Tools